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© 2020 Elsevier Inc. All rights reserved.Keywords:
Epilepsy self-management
COVID-19
Pandemic
Nursing research1. Introduction
The 2020 novel coronavirus SARS-CoV-2 and subsequent coronavirus
disease-19 (COVID-19) pandemic has caused unprecedented societal dis-
ruption worldwide. Social distancing mandates combined with extreme
stress on the United States (US) healthcare system have rendered daily
life in the US nearly unrecognizable. While most Americans' daily lives
and routines have markedly changed during the pandemic, Americans
with chronic disease, including epilepsy, are at unique risk for health-
related disruptions. Both Federal and state mandates put in place to
quell the spread of COVID-19, and the risk of contracting the virus, have
potentially created unique barriers for those with epilepsy.
First reported in China, COVID-19 is caused by a novel virus that
leads to respiratory illness in varying degrees of severity, from asymp-
tomatic to respiratory failure and death. Nearly 3 million cases of
COVID-19 have been confirmed globally, with the US currently having
the most at nearly 1 million confirmed cases; nearly 200,000 people
[1], including more than 50,000 Americans [2], have died from COVID-
19. Given its novelty, COVID-19 has been especially difficult to contain,
with public health experts scrambling to determine details about the
virus' spread and ability to live on surfaces. The unknown aspects of
the highly contagious virus' spread and effective treatment have caused
Federal- and state-level government action on a scale not seen sincesome states enacted social distancing during the 1918 Spanish Flu
pandemic [3].
President Trump has ordered the nation to follow drastic social dis-
tancing guidelines, which include staying at least six feet apart from
others outside of family, only leaving the house for essential purposes,
and working from home whenever possible. Universities and schools
across the nation have halted in-person classes, transitioning to online
learning, and 80% of Americans are under governor-enacted lockdown
orders. A majority of states have restricted gatherings and prohibited
all but essential travel outside the home; some states have formal “shel-
ter-in-place” orders in effect [4]. Even in states beginning to open, daily
environments are far from normal.
In themidst of a personal protective equipment and ventilator short-
age, governors have halted nonemergent surgeries and procedures, and
many health clinics are closed or only seeing patients in the event of an
emergency [5]. These necessary precautions have resulted in not only
economic collapse but also extreme alterations in a healthcare system
on which 3 million Americans rely for treatment and management of
their epilepsy, a condition which the Centers for Disease Control and
Prevention (CDC) has indicated increases the risk for serious COVID-
19 infection [6]. In themidst of a healthcare crisis focused on preventing
and treating COVID-19, another question arises—how does the pan-
demic affect the health of patients not affected by COVID-19, and espe-
cially those managing chronic diseases like epilepsy? This question is
especially important to consider given that the nation will likely have
to engage in additional rounds of social distancing until a vaccine for
COVID-19 is available [7].
Table 1
Demographic information, N = 94.
Sex –Male n = 47 (50%)
– Female n = 47 (50%)
Age Mean = 36, range: 19–88
Caregiver/PWE – Caregiver n = 16 (17%)
– PWE n = 78 (83%)
Ethnicity –White n = 75 (80%)
– African American n = 9 (9%)
– American Indian/Alaskan native n = 4 (4%)
– Native Hawaiian/Pacific Islander n = 3 (4%)
– Asian n = 2 (2%)
– Other n = 1 (1%)
Area of United
States
–Midwest n = 28 (30%)
– Northeast n = 18 (19%)
–Mid-Atlantic n = 17 (18%)
–West n = 16 (17%)
– Northwest n = 6 (7%)
– Southeast n = 6 (6%)
– Southwest n = 3 (3%)
Annual income – b$10,000 n = 5 (5%)
– $10K–$19,999 n = 6 (6%)
– $20K–$29,999 n = 2 (3%)
– $30K–$39,999 n = 10 (11%)
– $40K–$49,999 n = 15 (16%)
– $50K–$59,999 n = 12 (13%)
– $60K–$69,999 n = 7 (7%)
– $70K–$79,999 n = 13 (14%)
– $80K–$89,999 n = 7 (7%)
– $90K–$99,999 n = 3 (3%)
– $100K–$149,999 n = 11(12%)
– N$150,000 n = 3 (3%)
Employment
status
– Employed full-time n = 72 (77%)
– Employed part-time n = 13 (14%)
– Unemployed/looking for work n = 2 (2%)
– Unemployed/not looking for work n = 2 (2%)
– Student n = 3 (3%)
– Disability n = 2 (2%)
Education – High school graduate n = 4 (4%)
– Some college n = 7 (7%)
– 2-Year college degree n = 10 (10%)
– 4-Year college degree n = 60 (65%)
–Master's degree n = 12 (13%)
– Doctoral degree n = 1 (1%)
Relationship
status
–Married n = 70 (74%)
–Widowed n = 3 (3%)
– Divorced n = 10 (10%)
– Separated n = 1 (1%)
– Single/never married n = 5 (6%)
– Partnered or dating but not married n = 5 (6%)
Seizure
frequency
–Well-controlled, periods of seizure freedom one year or greater
n = 28 (30%)
– Somewhat well-controlled, with periods of seizure freedom six
months to one year n = 47 (50%)
– Uncontrolled, with periods of seizure freedom three to six
months n = 10 (11%)
– Very uncontrolled, with periods of seizure freedom less than
three months n = 6 (6%)
– Extremely uncontrolled, with period of seizure freedom less
than one week n = 3 (3%)
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outcomes [8] and refers to a patient managing the treatments and day-
to-day lifestyle changes associated with epilepsy. Specifically, epilepsy
self-management is the process duringwhich patients incorporatemul-
tidimensional strategies that meet their self-identified needs tomanage
and cope with epilepsy within the context of their daily living; success-
ful management of both functioning in day-to-day life along with man-
agement of chronic illness requires the individual to continually
monitor health and functional status and take appropriate actions dur-
ing acute phases, and this management often involves a familial care-
giver [9]. The COVID-19 pandemic creates a rare opportunity to
explore how epilepsy self-management is altered when societal, eco-
nomic, and healthcare structures do not exist in their usual forms in
the US. The purpose of this descriptive study was to, from the perspec-
tive of adult peoplewith epilepsy (PWE) and caregivers of PWE, explore
the effects of the current pandemic and resulting societal changes on
epilepsy self-management. Specifically, we sought to explore howman-
dated isolation, social distancing orders, closure of many businesses,
and COVID-19 infections have affected PWE and their caregivers' ability
to self-manage (control seizures, access medications, manage triggers,
and communicate with providers). Further, we explored the frequency
and severity of affective symptoms, as well as other PWE- and
caregiver-identified difficulties that have arisen during the pandemic.
2. Materials and methods
The study was submitted to the Indiana University IRB and deemed
exempt. Using socialmedia, an advertisement for the surveywas shared
via various epilepsy-related Facebook pages and via Twitter with the
appropriate hashtags to render it searchable (#COVID-19, #epilepsy,
#pandemic, and #research). Organic sharing of the advertisement
from members of these groups also occurred. All participants self-
referred to the study via the link embedded in the online advertisement.
Inclusion criteria were the following: age 18 years or older, a person
diagnosed with epilepsy taking antiseizuremedication OR the caregiver
of a child/loved one with epilepsy currently taking antiseizure medica-
tion for epilepsy, fluent in English, reliable access to the Internet, and
currently living in the US. Participants lacking these criteria were ex-
cluded and automatically directed to the end of the survey. The survey
included a total of 65 questions, 50 of which were relevant to this man-
uscript, and included questions related to demographics, perceived
changes in epilepsy self-management, social distancing, and affective
symptoms since the pandemic began. The data were collected over a
three-day period, from March 27 to March 30, 2020. During this three
day period, 31 states were under some version of stay-at-home orders.
Using SPSS version 26, descriptive statisticswere runon all quantita-
tive variables. Paired t-tests were used to detect statistically significant
differences on items that involved respondents providing a pre- and
postpandemic score. Qualitative comments were analyzed using tradi-
tional content analysis.
3. Results
3.1. Demographics
The surveywas accessed by 112 people. Five surveyswere discarded
because of high recaptcha scores on Qualtrics, indicating high likelihood
of bot completion. These five surveys were manually reviewed and
found to contain unreliable data. Thus, 107 completed the survey, and
94 participants completed every single survey item. The final sample
size was thus 94. Table 1 displays the demographics of the sample.
The gender of the sample was equally split, with 47 men and 47
women. The average age of respondents was 36 years (range: 19 to
88). There were 78 PWE and 16 caregivers. Participants were White
(80%), African American (9%), American Indian/Alaskan Native (4%),
Native Hawaiian or Pacific Islander (4%), Asian (2%), or Other (1%).Participants resided in the Midwest (30%), Northeast (19%),
Mid-Atlantic (18%), West (17%), Northwest (7%), Southeast (6%), and
Southwest (3%) regions of the US. Sixty respondents indicated that
they or their loved ones with epilepsy had not been tested for COVID-
19, 16 of whom reported that they had current symptoms (fever,
cough, or shortness of breath) that they believed could have been con-
tributed to COVID-19. Thirty-one participants reported that they or
their loved ones with epilepsy had been tested for COVID-19; of these,
7 reported that they (or their loved one with epilepsy) were COVID-
19 positive, while 24 reported negative COVID-19 testing results.
Sixty-nine percent of the sample (n = 65) indicated that they were
aware that the CDC has named PWE as high risk for serious COVID-19
infections, and the majority (82%) learned this from the Epilepsy
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statistically significantly correlated with other measures.
3.2. Social distancing
Respondents were asked to describe the degree to which they have
been practicing social distancing. On a scale of 0–10, with 0 being not
practicing social distancing at all and 10 practicing social distancing very
much, respondents' ratings averaged 8.03 (standard deviation (SD):
1.28, range: 4–10). Seventy-seven respondents indicated that they were
struggling to practice social distancing; 40 participants reported that
having to report to work for an essential job interfered with their ability
to practice social distancing. Other interferences with social distances
included having to work in order to make ends meet (n = 26), caring
for others outside the home (n = 22), and having social engagements
they were unable or unwilling to miss (n = 14). Table 2 includes addi-
tional results related to respondents' experiences with social distancing.
3.3. Epilepsy- and self-management-related changes
Weasked various questions aimed at determining how respondents'
epilepsy and epilepsy self-management have been affected by the pan-
demic.More than one-third (35%, n=33) of respondents indicated that
they or their loved ones have experienced increased seizure frequency
since pandemic onset. Of those who indicated worsening seizures dur-
ing the pandemic, on a scale of 0–10 with 0 being seizure frequency
has not increased at all and 10 being seizure frequency has increased
very much, the mean score was 6.88 (SD: 0.98, range: 3–8). Respon-
dents were asked to rank the degree to which several epilepsy self-
management-related activities (ability to control seizures, ability to
get seizure medication from pharmacy when needed, ability to reach
healthcare provider, ability to take/give seizure medication at the cor-
rect time, ability to manage stress, ability to stay in a normal sleeping
routine, and ability to track seizures and medication) were affected by
the pandemic. Ability to get medications from the pharmacy was most
affected by the pandemic, with 73% of the sample indicating that this
area of epilepsy self-management was made “much more difficult” by
the pandemic. More than 40% of the sample indicated that managing
seizures, managing stress, and reaching their epilepsy healthcare pro-
vider were made “muchmore difficult” by the pandemic. Fig. 1 displays
more detailed results of respondents' rankings in response to this
question.
Respondents were asked to rate the degree to which they feel confi-
dent that they could get timely help from their/their loved one's epi-
lepsy provider, hospital, and pharmacy using a 0–10 scale, with 0
being not at all confident and 10 being very confident. Respondents
were least confident in their ability to get timely help for epilepsy at a
hospital (mean = 5.19, SD: 2.69), followed by their confidence in re-
ceiving help from pharmacies (mean = 5.89, SD: 2.65). Respondents
had the highest level of confidence in receiving help from epilepsyTable 2
Additional social distancing questions, N = 94.
To what degree does epilepsy affect your decision to social
distance? (scale 1–10)
Mean: 7.48, SD 1.99,
range: 1–10
Compared to other people you know, would you say that
you began to engage in social distancing early on in this
pandemic or later? (scale 1–10, 1 = much earlier, 10 =
much later)
Mean: 5.83, SD 2.89,
range: 1–10
Compared to other people you know, would you say you
are social distancing more or less than they are? (scale
1–10, 1 = much less, 10 = much more)
Mean: 7.37, SD 1.34,
range: 4–10
How likely are you to continue to follow lockdown and
social distancing orders for the duration of the
pandemic, even if it lasts for months? (scale 1–10, 1 =
not at all likely, 10 = very likely)
Mean: 7.58, SD 1.42,
range: 2–10providers (mean = 5.91, SD: 2.44), resulting in the highest level of
confidence being just above “somewhat confident.”3.4. Affective symptoms
Participants were asked to describe the degree to which their sup-
port networks, feelings of isolation, and anxiety had changed as com-
pared with before the pandemic. Respondents rated the strength of
their social support networks using a 10-point Likert scale (0 = not at
all strong, 10 = very strong) before and after the pandemic, and there
was a statistically significant difference in pre- and postpandemic social
support network strength (mean score pre = 7.52; mean score post =
7.41; t = 3.02, p b .003). The samewas true for perceived isolation pre-
and postpandemic (mean score pre = 6.27; mean score post = 7.18; t
= 4.12, p= .000). Using the PROMIS anxiety scale [10], respondents re-
ported statistically significant higher levels of anxiety postpandemic
than prepandemic (mean score pre = 22.2; mean score post = 26.7; t
=−6.86; p= .000). Asked to rate how they were copingwith the cur-
rent pandemic on a scale of 0–10, with 0 being not at all and 10 being
very well, the mean score was 7.08 (SD: 1.89; range: 0–10).3.5. Qualitative comments
Respondents were asked to write free text regarding any other
thoughts they had about how the COVID-19 pandemic was affecting
their or their loved one's epilepsy. Forty-five respondents (35 PWE
and 10 caregivers) left remarks.
3.5.1. Difficulties with social distancing
Many (n = 23) respondents described how current responsibilities
interfered with social distancing. One participant stated, “I live alone,
so grocery shopping and pharmacy are all onme.” Others reported hav-
ing to continue to report to work or other volunteer duties, which
threatened their ability to social distance. “I work at a post office, and
sometimes we are not six feet apart” wrote one participant, while an-
other stated, “I work part time at a church with a food pantry which is
essential…While a lot of practices have been put in place to help social
distance while doing this, there is still some interaction. I also do not
drive due to my seizures so I need to rely on others for transportation,
which has limited my ability to social distance.” Another participant
remarked, “I have to report to work where 50 people are daily.” Others
noted that the ability towork from home has been very helpful in social
distancing, “With the ability to telework 100%… we were able to pre-
pare early by stocking food supplies to limit trips out of the house and
obtain 90 day supplies of antiseizure meds, and critical vitamins and
minerals for health stability. If we were not able to telework we would
sufferwith caring for our daughter and providing a safe situation for sei-
zure monitoring.”
3.5.2. Impact on seizure frequency and severity
Nine of 33 respondents who indicated a worsening of seizure fre-
quency and/or severity left comments about how the pandemic has di-
rectly affected their seizure frequency and severity. According to one
respondent, “I'm having a lot more complex partial seizures. This
week I had one every day, they usually only occur 1 to 3 times per
month. And I had a tonic clonic that was almost 8 minutes & the vns
didn't seem to help like it usually does.” Caregivers reported similar sei-
zure increases, with one stating, “He has had more seizures in the past
week…since all this started.”Others respondedwith the exact numbers
of seizures they have experienced since the onset of the pandemic, with
respondents reporting an increase by 3 (two respondents), 4 (two re-
spondents), 5, and 10 (three respondents), seizures beyond their nor-
mal seizure frequency since pandemic onset.
Fig. 1. Self-management difficulty rankings.
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Some respondents reported changes that directly affected their ability
to self-manage their epilepsy or that of their loved ones. Respondents
reported difficulty with maintaining a normal sleep routine, managing
stress, obtaining prescriptions, and reaching healthcare providers. As
one respondent explained, “It is more difficult to obtain medications
from the pharmacy due to reduced hours, living alone and not having
adequate transportation without ride sharing (which has been greatly
reduced in this area currently). Doctors are not accepting appointments
except for sick patients, so follow ups are nonexistent currently. There is
added stress from work, which also makes a normal sleep routine more
difficult. All of these things ultimately lead to poor seizure control over
time.” Another respondent noted, “With social distancing it has beenmore difficult to get the medications when needed. Stress has also been
a factor just worrying about if you were to have a seizure that we
would need to go to the hospital and being exposed there.” Another
respondent found that family members being home most of the time
also affected self-management. “It's changed my daily routine & that of
the people I live with (for instance my brother being out of school) so
my sleep has changed. He's a teen & sees this as a longer summer vaca-
tion, so he's staying up late & keepingmeup. Stress has been the hardest.”
One respondent explained the inability to get epilepsy-related questions
answered during this time, stating “You cannot get help for things that
are not life or death right now, including small seizures or questions
about medications…it's not clear when or if I am allowed to call them
with a question if it's not an emergency.” Similarly, a caregiver shared, “I
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about 7 months and I still have tons of questions but am afraid to ask
right now because I know everyone else has it far worse.”
3.5.4. Fear
Several respondents spoke of being fearful of contracting COVID-19 or
having care rationed in the event they or their loved ones needed hospi-
talization related to seizures. As one respondent explained, “I dare not go
to the hospital for regular testing because I am worried that the hospital
will take in many patients infected with the virus. I also dare not go to
the pharmacy, which makes me feel panic.” One respondent with
epilepsy explained fear regarding COVID-19's effect on epilepsy, stating,
“[I have] fear of getting the virus. I have seizure clusters with fevers so
I'm worried what will happen if I get it. Hearing some kind of comforting
word fromaneuro, that Iwon't die if I get itwould behelpful.”A caregiver
of a childwith epilepsy noted being concerned about rationing of ventila-
tors, stating, “Worried that if she needs any kind of hospital care she will
be less likely to receive a ventilator— not likely if she get Co-Vid to get a
vent…her cognitive function is greatly delayed and if care is rationed she
is in a group thatwill be at the bottomof the list. Thatworriesmegreatly.”
4. Discussion
Our results indicate that the ongoing COVID-19 pandemic has
affected the ability of PWE and caregivers of PWE to effectively self-
manage epilepsy in many ways. While there is no prior pandemic liter-
ature to which we can compare our results, it is not surprising that, in a
time during which our typical social structure and healthcare system
are upended, PWE are especially affected.
A large portion of the sample reported difficulties following social
distancing guidelines. While there is no published survey of the general
public's difficulties with social distancing, these things making social
distancing difficult to achieve (need to go towork, caring for others out-
side home) for this sample are likely not specific to PWE or their care-
givers. However, respondents also reported that they felt they began
engaging in social distancing earlier than others they know, and that
they were practicing social distancing more than others around them
(Table 2). The sample's early adoption and more strict adherence to so-
cial distancing guidelines may be due to the presence of epilepsy, as re-
spondents indicated that their or their loved one's epilepsywas a major
factor in their decision to social distance, and nearly 70% of respondents
indicated that they knew that the CDC has named PWE as a high-risk
group for serious COVID-19 infection. This is an encouraging result—
the CDC's classifications of high-risk groups appears to have been
well-disseminated to this sample, and they are also taking steps (social
distancing) to prevent COVID-19 given their or their loved one's high-
risk COVID-19 infection status. Most respondents (82%) learned of the
CDC classification via the Epilepsy Foundation's social media, indicating
that sharing of CDC guidelines in this manner is effective and should be
repeated, and even amplified, in the event of future COVID-19 out-
breaks. Because some respondents knew this information but were un-
sure of its full meaning (worry about COVID-19 meaning automatic
death for someonewith epilepsy), it is important to consider addressing
details of what it means to be on the CDC's high-risk list.
Our results demonstrate a clear disruption in epilepsy self-
management during the pandemic, in many cases leading to increased
seizure frequency or a deterioration in self-management that puts PWE
at higher-than-normal risk for seizures. In response to both quantitative
and qualitative questions, respondents indicated problems managing
epilepsy in large part due to difficulty obtaining medications from phar-
macies, securing appointments with epilepsy providers, and disruption
in normal routine. These results suggest that the necessary changes
accompanying a pandemic like COVID-19 threaten the management of
epilepsy, and likely other conditions as well. Ahead of the next round of
social distancing or a new pandemic entirely, it is important to put in
place structures that will ease patients' ability to access medications andproviders. Physicians and other providers caring for PWE should consider
3-month prescriptions for antiseizure drugs, at least until a vaccine is
widely available. From a more system-level perspective, there is a need
to devise a system that will allow people who require medication for
chronic diseases, including epilepsy, to access their medications in the
event of more social distancing or another outbreak. Prescription mail
delivery (especially for PWE who lack transportation) and no contact
drive-thru service are potential options, though respondents in this
sample also noted that restricted pharmacyhours contributed to their dif-
ficulty in getting their medications, while others who cannot drive may
struggle to find transportation to the pharmacy in a lockdown. State
and Federal funding may need to be considered to allow pharmacies to
continue to offer services that will prevent disruption of medications for
PWE and others with chronic conditions. Regarding lack of access to
epilepsy providers, the use of robust video health visit platforms will be
most helpful and will hopefully already exist during subsequent out-
breaks; the providers of respondents in this sample required time to set
up these systems. As the pandemic wanes, epilepsy clinics should con-
sider prioritizing the maintenance of these virtual visit platforms, includ-
ing helping patients and caregivers to feel comfortable using them in
preparation for the next wave. A downside of virtual video visits is that
a strong internet connection is required. Given that virtual health visits
have led to higher satisfaction and lower no-show rates, this may be an
opportunity to make them more mainstream for maintenance epilepsy
care [11].
However, those in rural communities who may have inferior inter-
net, or none at all, may not be able to participate in virtual visits.
While Internet companies have offered to connect low-income families
with free Internet during the pandemic [12], some live in areas where
broadband is not available. In these cases, the use of telehealth (visits
by telephone) could be amore appropriate and reliable option.Most im-
portantly, practices must communicate clearly with patients and care-
givers regarding the plan for scheduling a visit, getting questions
answered, etc., as in our sample, a lack of understanding of how to
reach providers, and whether a question was “urgent enough” to call
appeared to contribute to issues with provider communication.
Respondents' reports of altered and poorer quality of sleep since the
onset of the pandemic is concerning given that lack of sleep is a known
seizure trigger for many PWE [13–16]. In preparation for more COVID-
19 outbreaks and subsequent social distancing and changes in the
healthcare system, epilepsy physicians and other providers should
prioritize self-management skill-building, particularly regarding sleep,
with their patients and caregivers, which could be done via nurses,
including Advanced Practice Nurses. Web-based self-management in-
terventions, such as WebEASE [17], which provides training in sleep-
related management, could also be used leading up to and during the
next outbreak of COVID-19 or in a similar situation. It is also imperative
that PWE and their caregivers have a reliable way to communicate with
epilepsy providers in the event that a subsequent outbreak results in
changes in routine, such as altered sleep, that increase their seizure risk.
Our sample's reports of increased isolation, anxiety, and stress dur-
ing the pandemic are also troubling. During normal circumstances,
PWE, aswell as family caregivers, tend to be socially isolatedwhen com-
pared with the general public [18]. In fact, this sample had a significant
level of social isolation prepandemic (mean: 6.27 on a 0–10 scale). This
isolation puts them at risk of depressive symptoms, anxiety, and lower
quality of life [19]. The significant increase in the social isolation seen
in both PWE and caregivers during the pandemic is concerning, as it
puts them at risk for an exacerbation of existing isolation-related prob-
lems. Further, the significant decrease in respondents' perceived levels
of social support after pandemic onset suggests that members of our
sample, socially isolated at baseline, are even more isolated now but
with less social support. In anticipation of more social distancing in
the future, PWE and caregivers should be educated on how to mitigate
social isolation. Those PWEwho have existingmental healthcare practi-
tioners should be encouraged to reach out to them for virtual visits.
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the CDC and Epilepsy Foundation websites, where resources regarding
social isolation, including virtual support groups, can be found, and
those who continue to struggle with social isolation can be referred to
an appropriate mental healthcare provider, even in the midst of a
pandemic.
Our sample's significant increase in anxiety and stress from pre- to
postpandemic onset is not surprising but is concerning in that it could
put them at higher risk for seizures [20]. While some of these increased
anxiety and stress was related to the pandemic in general, some was
specific to epilepsy: concern about what would happen if they did con-
tract the virus (e.g., were they more likely to die given the presence of
epilepsy), worry about not being able to access medications or
healthcare provider, and fear of not receiving needed care due to ration-
ing. Thus, epilepsy providers or their liaisons should be sure to commu-
nicate to patients and caregivers about how they could be more or less
affected by COVID-19 given their epilepsy, and explain truths about
care rationing, and its potential to affect PWE. As stated earlier, counsel-
ing PWE and caregivers on ways in which to secure medications will
also help to allay fears in this area.
The overall findings of the current study also underscore that any
major change in routine—pandemic-related or not—can put a person's
epilepsy self-management and associated outcomes at risk. Prior stud-
ies have indicated that epilepsy self-management is a complex process
that changes based on a person's perceived health and all levels of his
or her environment, from interpersonal to societal. In short, epilepsy
self-management is not a stagnant concept, and can be destabilized
when a person's environment changes [9]. Development of robust
self-management skills for PWE should thus be prioritized, including
for very disruptive instances, such as another pandemic, periods of so-
cial distancing, or any life-altering event.
4.1. Limitations
This study is not without limitations. First, we were not able to col-
lect data on important variables (affective symptoms, for example)
prior to the pandemic. Rather, we had to rely on respondents' memo-
ries, asking them to answer questions considering both normal and
present (pandemic) circumstances. Second, our sample represents
mostly White, middle-class people with college degrees. It is important
to recognize that our results may not be as generalizable to populations
less well-represented in our sample. Finally, our sample of 94 is some-
what small; if possible, similar research should be repeated with a
larger, more diverse sample in the event of a similar situation.
5. Conclusions
The COVID-19 pandemic has upended normal life, and current find-
ings demonstrate that it has also disrupted epilepsy self-management
for PWE and their caregivers. During this unusual time, most medical
care is understandably directed at managing COVID-19 and saving lives
of those affected. While there has been and will be a future need to put
off “nonurgent” healthcare during subsequent local and state shut
downs, those citizens with chronic diseases, including epilepsy, have
daily management needs that do not go away during a pandemic or
other life-altering change; conversely, these needs are heightened. Physi-
cians and nurseswho provide care to PWE should prioritizemaking plans
with PWE and caregivers in the event of significant disruptions.Members
of our sample would have benefitted greatly from clear-cut guidancefrom epilepsy providers regarding how to communicate with them and
that theywere allowed to do so. In light of current results, the professional
epilepsy community should consider treatment and management guide-
lines for pandemic-like societal and health system disruptions. In addi-
tion, prioritization of robust self-management skills upon epilepsy
diagnosis and continuing throughout the disease course remains neces-
sary for PWE and the caregivers who assist them.
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